{"url_path":"/sec/gctk/8-k/2026-09-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-09-11","source_url":"https://www.sec.gov/Archives/edgar/data/1506983/0001493152-26-042428-index.html","accession_number":"0001493152-26-042428","cik":"0001506983","ticker":"GCTK","issuer_name":"Glucotrack, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1506983/0001493152-26-042428-index.html","primary_entity_key":"0001506983","primary_entity_name":"Glucotrack, Inc."},"word_count":142,"has_tables":true,"body_markdown":"**Item\n9.01. Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n4.1\n \n[Form of Note, dated September 10, 2026](ex4-1.htm)\n\n4.2\n \n[Form of Warrant, dated September 10, 2026](ex4-2.htm)\n\n4.3\n \n[Form of Placement Agent Warrant, dated September 10, 2026](ex4-3.htm)\n\n10.1\n \n[Form of Securities Purchase Agreement, dated September 10, 2026, by and between Glucotrack, Inc. and the purchasers party thereto](ex10-1.htm)\n\n10.2\n \n[Placement Agency Agreement, dated September 10, 2026, by and between Glucotrack, Inc. and Dawson James Securities, Inc.](ex10-2.htm)\n\n99.1\n \n[Press Release, dated September 11, 2026](ex99-1.htm)\n\n104\n \nCover\nPage Interactive Data File (embedded within the inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\nDate:\nSeptember 11, 2026\n \n \n\n \n \n \n\n \n**GLUCOTRACK,\nINC.**\n\n \n \n \n\n \nBy:\n*/s/\nErik Emerson*\n\n \nName:\nErik\nEmerson\n\n \nTitle:\nChief\nExecutive Officer"}